semaglutide gastroparesis lawsuit in michigan Ozempic, Mounjaro manufacturers sued over claims of "stomach paralysis" side effects michigan glp-1 intestinal paralysis legal

Originally developed for managing type 2 diabetes, semaglutide has garnered attention for its potential benefits in weight management

Therapy duration did not vary by IBS subtype (P=0.59)

At the time, gastric bypass was often the only serious intervention available for severe obesity

An enzyme in the small intestine called gamma-glutamyl transpeptidase (GGT) is specifically responsible for dismantling the glutathione molecule, making traditional capsules highly inefficient for raising systemic levels

However, some individuals may notice rebound effects, such as an increase in appetite or blood sugar levels, which could lead to weight regain or poorly managed diabetes